Replies to post #5602 on InVivo Therapeutics Holdings Corp (NVIVQ)

[DDobserver]

Have you checked the charts lately? I do not think we are looking at the same chart or considering the same company.

Executives are not buying into the company. They are being compensated well along with there stock options. No cash flow until 2018/2019. Little to no news from the company regarding updates of patients. Burning over a million a month in cash. Cash is depleted by the end of 2017. So what then another dilution? Lets see last time was four shares for one share and that was not enough, will they do eight shares for one share or why not go twelve shares for one share? Will the lucrative warrants be issued to cover expenses for a few more years to "friends or insiders"? Now the chief medical officer "retires". If you look at the amount of hours(read the corporate documents) she spent per week at Invivo and consider her handsome compensation you should ask why would she retire? Does she know something that the shareholders have not been told?

So they want to also go into the socialized medicine countries in Europe and Canada. I have lived in Europe and health care rationing is a reality. Those systems are worse than Obama Care which is good if you are broke, without a job, or the working poor, but if you are wanting to collect profits from these countries...good luck.